Patents by Inventor Bernhard Keppler

Bernhard Keppler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160012249
    Abstract: A computer based method includes collecting biometric, physiological and other local data from one or more sensors or medical devices, including physiological data and/or conditions of a person. Remote data is collected including treatment information provided by a physician, and data obtained from various data transmitting sources such as RFID fitted pill dispensers, medication dispensers, intra body devices, medical data sensors and medical apparatus. All the data is preferably obtained in real time and stored in an encrypted database which is either maintained in a local data storage device or in a remotely located secure database. Control and access to any or parts of the data collected is controlled by the person, preferably secured using biometric information, so each individual person can maintain control over the collected information, and prevent inadvertent disclosures to persons without a need to know.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 14, 2016
    Applicant: Ellipson Data LLC
    Inventor: Bernhard Keppler
  • Publication number: 20130331368
    Abstract: A therapeutic method for treating hepatocellular carcinoma is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: August 12, 2013
    Publication date: December 12, 2013
    Applicant: Niiki Pharma Acquisition Corp. 2
    Inventors: Walter Berger, Petra Heffeter, Bernhard Keppler, Hooshmand Sheshbaradaran
  • Publication number: 20130310356
    Abstract: Methods and compositions for treating brain cancer are disclosed, including refractory brain cancer.
    Type: Application
    Filed: July 26, 2013
    Publication date: November 21, 2013
    Applicant: Niiki Pharma Acquisition Corp. 2
    Inventors: Hooshmand Sheshbaradaran, Rebecca Baerga, Jenel Cobb, Mojtaba Seied Valiahdi, Bernhard Keppler
  • Publication number: 20130116225
    Abstract: Methods and compositions for treating hematological cancer are disclosed, including refractory or resistant hematological cancer.
    Type: Application
    Filed: August 13, 2012
    Publication date: May 9, 2013
    Applicant: NIIKI PHARMA INC.
    Inventors: Hooshmand SHESHBARADARAN, Aram PROKOP, Rebecca Baerga, Jenel Cobb, Mojtaba Seied Valiahdi, Soo-Young LEE, Bernhard KEPPLER
  • Publication number: 20130090321
    Abstract: Methods and compositions for treating brain cancer are disclose including refractory brain cancer.
    Type: Application
    Filed: August 27, 2012
    Publication date: April 11, 2013
    Applicant: NIIKI PHARMA INC.
    Inventors: Hooshmand SHESHBARADARAN, Rebecca BAERGA, Jenel COBB, Mojtaba Seied VALIAHDI, Bernhard KEPPLER
  • Publication number: 20120115833
    Abstract: A therapeutic method for treating hepatocellular carcinoma is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: October 17, 2011
    Publication date: May 10, 2012
    Applicant: NIIKI PHARMA INC.
    Inventors: Walter Berger, Petra Heffeter, Bernhard Keppler, Hooshmand Sheshbaradaran
  • Patent number: 7919486
    Abstract: The invention relates to the use of gallium (III) complexes for the treatment of melanomas.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: April 5, 2011
    Assignee: Niiki Pharma Inc.
    Inventor: Bernhard Keppler
  • Patent number: 7589084
    Abstract: The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3-n-p-2pr[RuX6-n-p-q-2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)S??(II).
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: September 15, 2009
    Assignee: Niiki Pharma, Inc.
    Inventor: Bernhard Keppler
  • Publication number: 20090137620
    Abstract: The invention relates to the use of gallium (III) complexes for the treatment of melanomas.
    Type: Application
    Filed: August 13, 2008
    Publication date: May 28, 2009
    Inventor: Bernhard Keppler
  • Patent number: 7485659
    Abstract: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit. The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3?n?p?2pr[RUX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)s??(II). Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B?H)3?n?p?2pr[RUX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(III) with a compound of the general formula (IV) MX???(IV).
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: February 3, 2009
    Assignee: Faustus Forschungs CIE, Translational Cancer Research GmbH
    Inventor: Bernhard Keppler
  • Patent number: 7338946
    Abstract: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit. The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3?n?p?2pr[RuX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)S.??(II) Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B?H)3?n?p?2pr[RuX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(III) with a compound of the general formula (IV) MX?.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: March 4, 2008
    Assignee: Faustus Forschungs Cie. Translational Cancer Research GmbH
    Inventor: Bernhard Keppler
  • Publication number: 20080045806
    Abstract: There is disclosed a method comprising the steps of: 1. sensing biometric characteristic data of an individual; 2. comparing said biometric characteristic data to characteristic data of predetermined registered individuals and determining whether said individual is registered; 3. sensing physiological characteristic data of said individual; 4. comparing said physiological characteristic data with a predetermined range of acceptable values for said physiological characteristic data; and 5. sensing a parameter characteristic of a security condition; 6. comparing said parameter characteristic of a security condition with a predetermined range of acceptable values for said parameter 7. transmitting a signal if said individual is registered, if said physiological characteristic data is within said predetermined range or not and if said parameter characteristic of a security condition is within said range of acceptable values for said parameter.
    Type: Application
    Filed: April 4, 2007
    Publication date: February 21, 2008
    Inventor: Bernhard Keppler
  • Publication number: 20070293468
    Abstract: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit. The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3-n-p-2pr[RuX6-n-p-q-2rBn(H2O)p(OH)q(O)r]2r+1 ??(I) with a compound of the general formula (II) B?(HX?)S ??(II). Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B?H)3-n-p-2pr[RuX6-n-p-q-2rBn(H2O)p(OH)q(O)r]2r+1 ??(III) with a compound of the general formula (IV) MX???(IV).
    Type: Application
    Filed: April 3, 2007
    Publication date: December 20, 2007
    Inventor: Bernhard Keppler
  • Publication number: 20070293557
    Abstract: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit. The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3?n?p?2pr[RUX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)s??(II). Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B?H)3?n?p?2pr[RUX6?n?p?q?2rBn(H2O)p(OH)q(O)r]2r+1??(III) with a compound of the general formula (IV) MX???(IV).
    Type: Application
    Filed: April 3, 2007
    Publication date: December 20, 2007
    Inventor: Bernhard Keppler
  • Publication number: 20060251580
    Abstract: A conjugate includes at least one target-seeking unit, which specifically binds to receptors on the surface of endothelial cells, and at least one effector unit which is coupled to the unit by a linker. The effector unit exhibits at least one signal unit and optionally at least one therapeutic active substance. The target-seeking unit includes a lectin or a fragment or derivative thereof, wherein the lectin is not L-selectin and the signal unit includes a lanthanide ion.
    Type: Application
    Filed: December 6, 2005
    Publication date: November 9, 2006
    Inventors: Bernhard Keppler, Paul Debbage, Wolfgang Buchberger
  • Patent number: 7122643
    Abstract: Lanthanum compounds are provided having general formulas (I) Rni+Yin? and (II) Rb+Yb? which may be used as medicaments in the prophylaxis and/or treatment of cancer diseases.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: October 17, 2006
    Assignee: Faustus Forschungs Cie. Translational Cancer Research GmbH
    Inventor: Bernhard Keppler
  • Patent number: 7057059
    Abstract: A tumor-inhibiting platinum (II) oxalate complex and its use as a therapeutic agent are provided, in particular as a tumor-inhibiting medicament.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: June 6, 2006
    Assignee: Faustus Forschungs CIE. Translational Cancer Research GmbH
    Inventor: Bernhard Keppler
  • Patent number: 7019156
    Abstract: The invention relates to a compound of the general formula (I) where R1, R2, R3, R4, R1?, R2?, R3? and R4? are independently of one another hydrogen, C1–C15-alkyl, C2–C15-alkenyl, C2–C15-alkinyl, C3–C16-cycloalkyl, C3–C16-cycloalkenyl, aryl or a heterocyclus which in each case can be substituted or unsubstituted, Y is a physiologically compatible anion, and n is 1 or 2, as well as its application to the prophylaxis and/or tretment of cancer illnesses.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: March 28, 2006
    Assignee: Faustus Forschungs Cie. Translational Cancer Research GmbH
    Inventor: Bernhard Keppler
  • Publication number: 20060009445
    Abstract: This invention relates to anellated azepinone derivatives, a method of their production, metal complexes of the anellated azepinone derivatives as well as their use in the treatment of tumor diseases.
    Type: Application
    Filed: June 23, 2005
    Publication date: January 12, 2006
    Inventor: Bernhard Keppler
  • Patent number: 6921768
    Abstract: The invention relates to cerium compounds having general formulas (I) Rni+Yin? and (II) Rb+Yb+ and their application as medicaments in the prophylaxis and/or treatment of cancer diseases.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: July 26, 2005
    Assignee: Faustus Forschungs Cie. Translational Cancer Research GmbH
    Inventor: Bernhard Keppler